Cargando…
Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection
Non-steroidal anti-inflammatory drugs (NSAIDs) have an optional prescription status that has resulted in frequent use, in particular for the symptomatic treatment of fever and non-rheumatic pain. In 2019, a multi-source analysis of complementary pharmacological data showed that using NSAIDs in these...
Autores principales: | Micallef, Joëlle, Soeiro, Thomas, Jonville-Béra, Annie-Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204680/ https://www.ncbi.nlm.nih.gov/pubmed/32418728 http://dx.doi.org/10.1016/j.therap.2020.05.003 |
Ejemplares similares
-
COVID-19 and NSAIDs: Primum non nocere
por: Micallef, Joëlle, et al.
Publicado: (2020) -
Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy
por: Soeiro, Thomas, et al.
Publicado: (2021) -
French Pharmacovigilance Public System and COVID-19 Pandemic
por: Grandvuillemin, Aurélie, et al.
Publicado: (2020) -
Monitoring the safety of drugs and COVID-19 vaccines by the French Pharmacovigilance Centers during the pandemic: A win-win bet with Health Authorities!
por: Jonville-Bera, Annie Pierre, et al.
Publicado: (2023) -
Serious Neurological Adverse Events of Ceftriaxone
por: Lacroix, Clémence, et al.
Publicado: (2021)